Showing results (2271-2280 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|December 10, 2013
Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trialFrancesca Caumo, Daniela Bernardi, Stefano Ciatto, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Personalizing extent of breast cancer surgery according to molecular subtypesMonica Morrow
Breast (Edinburgh, Scotland)|October 1, 2013
Close/positive margins after breast-conserving therapy: additional resection or no resection?William C Wood
Breast (Edinburgh, Scotland)|October 1, 2013
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effectsFelix Sedlmayer, Franz Zehentmayr, Gerd Fastner
Breast (Edinburgh, Scotland)|October 1, 2013
Follow-up tests to detect recurrent disease: patient's reassurance or medical need?Ian E Smith, Gaia Schiavon
Breast (Edinburgh, Scotland)|October 1, 2013
Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancerMaysa Abu-Khalf, Lajos Pusztai
Breast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Breast (Edinburgh, Scotland)|August 30, 2016
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study populationS Redana, A Sharp, H Lote, et al.
Breast (Edinburgh, Scotland)|January 19, 2010
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapyStephanie L Hines, Jeff A Sloan, Pamela J Atherton, et al.
Pageof 367